共 50 条
- [1] Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm InfantsWith Respiratory Distress Syndrome [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (16): : 1613 - 1614
- [2] Minimally invasive surfactant therapy vs sham treatment and death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome-reply (vol 327, pg 1614, 2022) [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (21): : 2151 - 2151
- [3] Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome The OPTIMIST-A Randomized Clinical Trial [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (24): : 2478 - 2487
- [4] OPTIMIST-A Trial Investigators. Minimally invasive surfactant therapy vs sham treatment and death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome-reply. (vol 327, pg 1614, 2022) [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (11): : 2151 - 2151
- [5] Minimally Invasive Surfactant Therapy to Prevent Bronchopulmonary Dysplasia in Extremely Preterm Infants [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (24): : 2475 - 2476
- [9] Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (03): : 226 - 230